Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of therapeutic concentration of lithium on live HEK293 cells; increase of Na+/K+-ATPase, change of overall protein composition and alteration of surface layer of plasma membrane.
Vosahlikova M, Ujcikova H, Chernyavskiy O, Brejchova J, Roubalova L, Alda M, Svoboda P. Vosahlikova M, et al. Among authors: alda m. Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1099-1112. doi: 10.1016/j.bbagen.2017.02.011. Epub 2017 Feb 13. Biochim Biophys Acta Gen Subj. 2017. PMID: 28215700
Corrigendum to "Induction of oxidative stress by long-term treatment of live HEK293 cells with therapeutic concentration of lithium is associated with down-regulation of δ-opioid receptor amount and function" [Biochem. Pharmacol. 154 (2018) 452-463].
Vosahlikova M, Ujcikova H, Hlouskova M, Musil S, Roubalova L, Alda M, Svoboda P. Vosahlikova M, et al. Among authors: alda m. Biochem Pharmacol. 2018 Oct;156:396-397. doi: 10.1016/j.bcp.2018.09.001. Epub 2018 Sep 13. Biochem Pharmacol. 2018. PMID: 30218916 No abstract available.
Na+/K+-ATPase level and products of lipid peroxidation in live cells treated with therapeutic lithium for different periods in time (1, 7, and 28 days); studies of Jurkat and HEK293 cells.
Vosahlikova M, Roubalova L, Ujcikova H, Hlouskova M, Musil S, Alda M, Svoboda P. Vosahlikova M, et al. Among authors: alda m. Naunyn Schmiedebergs Arch Pharmacol. 2019 Jul;392(7):785-799. doi: 10.1007/s00210-019-01631-4. Epub 2019 Feb 21. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 30790031
Na+/K+-ATPase and lipid peroxidation in forebrain cortex and hippocampus of sleep-deprived rats treated with therapeutic lithium concentration for different periods of time.
Vosahlikova M, Roubalova L, Cechova K, Kaufman J, Musil S, Miksik I, Alda M, Svoboda P. Vosahlikova M, et al. Among authors: alda m. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109953. doi: 10.1016/j.pnpbp.2020.109953. Epub 2020 Apr 29. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32360816
Discontinuation of lithium because of side effects.
Hajek T, Alda M, Grof P. Hajek T, et al. Among authors: alda m. J Psychiatry Neurosci. 2011 Nov;36(6):E39-40. doi: 10.1503/jpn.110117. J Psychiatry Neurosci. 2011. PMID: 22011562 Free PMC article. No abstract available.
Telomere length in bipolar disorder and lithium response.
Squassina A, Pisanu C, Corbett N, Alda M. Squassina A, et al. Among authors: alda m. Eur Neuropsychopharmacol. 2017 Jun;27(6):560-567. doi: 10.1016/j.euroneuro.2015.10.008. Epub 2015 Nov 24. Eur Neuropsychopharmacol. 2017. PMID: 26621262 Review.
496 results